Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen in growth hormone deficiency and chronic heart failure
NCT03775993Phase 3Unknown
- Sponsor
- University of Naples Federico II
- Start
- Mar 2019
- Primary completion
- Mar 2022
01
Overview
Phase 3, randomised, double-blind trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by University of Naples Federico II. Primary endpoint: peak oxygen consumption at 1 year. Status: unknown.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT03775993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03775993.